Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.76
+0.04 (0.29%)
At close: Jan 16, 2026, 4:00 PM EST
13.80
+0.04 (0.32%)
After-hours: Jan 16, 2026, 7:44 PM EST
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 11 analysts that cover Janux Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $59.18, which forecasts a 330.09% increase in the stock price over the next year. The lowest target is $29 and the highest is $150.
Price Target: $59.18 (+330.09%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Janux Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 4 | 6 | 6 |
| Buy | 4 | 5 | 5 | 5 | 4 | 4 |
| Hold | 1 | 1 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 11 | 11 | 11 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +118.02% | Jan 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $29 | Buy | Maintains | $48 → $29 | +110.76% | Dec 17, 2025 |
| Stifel | Stifel | Strong Buy Maintains $46 → $38 | Strong Buy | Maintains | $46 → $38 | +176.16% | Dec 2, 2025 |
| Clear Street | Clear Street | Strong Buy Maintains $80 → $32 | Strong Buy | Maintains | $80 → $32 | +132.56% | Dec 2, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $58 → $49 | Strong Buy | Maintains | $58 → $49 | +256.10% | Dec 2, 2025 |
Financial Forecast
Revenue This Year
10.26M
from 10.59M
Decreased by -3.10%
Revenue Next Year
1.43M
from 10.26M
Decreased by -86.02%
EPS This Year
-2.05
from -1.28
EPS Next Year
-2.97
from -2.05
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 11.6M | 7.9M | ||||
| Avg | 10.3M | 1.4M | ||||
| Low | 9.8M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 9.1% | -23.2% | ||||
| Avg | -3.1% | -86.0% | ||||
| Low | -7.4% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -1.87 | -2.46 | ||||
| Avg | -2.05 | -2.97 | ||||
| Low | -2.51 | -4.51 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.